Theravit (Tablets) Instructions for Use
Marketing Authorization Holder
BAYER, JSC (Russia)
Manufactured By
Sagmel Inc. (USA)
ATC Code
A11AA04 (Multivitamins and trace elements)
Dosage Form
| Theravit | Coated tablets: 30 pcs. |
Dosage Form, Packaging, and Composition
Coated tablets of red-brown color, oval, biconvex; on the break – from white to light brown with inclusions of white color.
| 1 tab. | |
| Retinol acetate (vit. A) | 4000 IU |
| Betacarotene (vit. A) | 1000 IU |
| α-Tocopherol acetate (vit. E) | 30 IU |
| Colecalciferol (vit. D3) | 400 IU |
| Ascorbic acid (vit. C) | 90 mg |
| Thiamine mononitrate (vit. B1) | 3 mg |
| Riboflavin (vit. B2) | 3.4 mg |
| Pantothenic acid (in the form of calcium pantothenate) (vit. B5) | 10 mg |
| Pyridoxine hydrochloride (vit. B6) | 3 mg |
| Folic acid (vit. Bc) | 400 mcg |
| Cyanocobalamin (vit. B12) | 9 mcg |
| Nicotinamide (vit. PP) | 20 mg |
| Biotin (vit. H) | 30 mcg |
| Potassium (in the form of chloride) | 7.5 mg |
| Calcium (in the form of dicalcium phosphate) | 40 mg |
| Magnesium (in the form of oxide) | 100 mg |
| Phosphorus (in the form of dicalcium phosphate) | 31 mg |
| Iron (in the form of fumarate) | 27 mg |
| Copper (in the form of sulfate) | 2 mg |
| Zinc (in the form of oxide) | 15 mg |
| Manganese (in the form of sulfate) | 5 mg |
| Iodine (in the form of potassium iodide) | 150 mcg |
| Molybdenum (in the form of sodium molybdate) | 15 mcg |
| Selenious acid solution 0.9% in 90% 2,2-dichloropropionic acid (in the form of sodium selenate) | 10 mcg |
| Chromium (in the form of chloride) | 15 mcg |
Excipients: microcrystalline cellulose, stearic acid, magnesium stearate, croscarmellose sodium, silicon dioxide, starch.
Shell composition: gelatin, hypromellose, mannitol, titanium dioxide, red lake no. 40, blue lake no. 2.
30 pcs. – polypropylene bottles (1) – cardboard packs.
Clinical-Pharmacological Group
Multivitamins with macro- and microelements
Pharmacotherapeutic Group
Multivitamin agent + multimineral
Pharmacological Action
A combined preparation containing vitamins, minerals, and trace elements; its action is due to the properties of its constituent ingredients.
Indications
- Prevention and treatment of hypo- and avitaminosis;
- Deficiency of mineral substances in adults;
- In case of unbalanced or inadequate nutrition;
- During the recovery period after past illnesses.
ICD codes
| ICD-10 code | Indication |
| E50-E64 | Other types of nutritional deficiencies (E50-E64) |
| Z54 | Convalescence |
| Z73.0 | Burn-out |
| Z73.3 | Stress, not elsewhere classified (physical and mental strain) |
| ICD-11 code | Indication |
| 5B7Z | Malnutrition, unspecified |
| QB7Z | Convalescence, unspecified |
| QD85 | Burn-out |
| QE01 | Stress, not elsewhere classified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Take one tablet per day. Swallow the tablet whole with a sufficient amount of water. Do not chew or crush the tablet.
Administer the tablet after a meal to improve gastrointestinal tolerance and enhance the absorption of fat-soluble vitamins.
The standard course of treatment is 30 days, corresponding to one commercial package.
Initiate repeated courses of therapy only as recommended by a physician. The decision for re-administration should be based on a clinical assessment of nutritional status.
Do not exceed the stated daily dosage. The maximum daily dose is one tablet.
For long-term use beyond 30 days, seek medical supervision to monitor for potential hypervitaminosis, particularly of vitamins A and D.
Adverse Reactions
Allergic reactions are possible.
Contraindications
- Hypersensitivity to the components of the preparation;
- Childhood.
Pediatric Use
The use of this preparation in children is prohibited.
Special Precautions
Do not exceed the recommended dosage. It is not recommended to use Theravit concomitantly with other preparations containing vitamins to avoid overdose. Urine may turn yellow due to the presence of riboflavin in the preparation.
Storage Conditions
The preparation should be stored in a dry place at a temperature not exceeding 25°C (77°F). Keep out of reach of children.
Shelf Life
Shelf life– 3 years.
Do not use after the expiration date printed on the packaging.
Dispensing Status
The preparation is approved for use as an over-the-counter product.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer